Sign In
Buy ACAD
$25.87
-0.680 (-2.56%)
At Close: Jul 31, 2026
Avidity Partners Management LP Sells 93,933 Shares of ACADIA Pharmaceuticals Inc. $ACAD
03:50am, Saturday, 01'st Aug 2026
Avidity Partners Management LP cut its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) by 87.9% during the undefined quarter, according to its most recent Form 13F filing with the SEC
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference
05:57pm, Thursday, 30'th Jul 2026
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Canaccord Genuity 46th Annual Growth Conference on Wednesday, Augu
HRMY or ACAD: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 30'th Jul 2026
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or Acadia Pharmaceuticals (ACAD). But which of thes
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Tuesday, 28'th Jul 2026
Acadia (ACAD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
01:41pm, Monday, 27'th Jul 2026
Harmony Biosciences, Acadia, Biogen, Insmed and Agios show positive Earnings ESPs ahead of Q2 results, setting up closely watched earnings reports.
Acadia Pharmaceuticals: Why I'm Bullish Ahead Of The RADIANT Readout
09:27am, Monday, 27'th Jul 2026
Acadia Pharmaceuticals Inc. ended July on a high note. The top line results from the Phase 2 RADIANT study of remlifanserin in Alzheimer's disease psychosis are expected in August-October 2026. Acadia
Wall Street Analysts Believe Acadia (ACAD) Could Rally 30.89%: Here's is How to Trade
10:55am, Thursday, 23'rd Jul 2026
The mean of analysts' price targets for Acadia (ACAD) points to a 30.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
ACADIA Pharmaceuticals Inc. $ACAD Shares Acquired by Bessemer Group Inc.
03:40am, Wednesday, 22'nd Jul 2026
Bessemer Group Inc. lifted its stake in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) by 21,126.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commi
Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate
11:50am, Tuesday, 21'st Jul 2026
ACAD wins FDA's Fast Track status for remlifanserin in Alzheimer's disease psychosis as its phase II data readout approaches and phase III enrollment advances.
Allspring Global Investments Holdings LLC Buys 296,042 Shares of ACADIA Pharmaceuticals Inc. $ACAD
03:08am, Tuesday, 21'st Jul 2026
Allspring Global Investments Holdings LLC lifted its stake in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) by 44.9% during the undefined quarter, according to its most recent disclosure with the SEC. Th
Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis
09:05am, Monday, 20'th Jul 2026
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to remlifanserin, an investig
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026
04:05pm, Wednesday, 15'th Jul 2026
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S.
An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?
04:50pm, Saturday, 11'th Jul 2026
Principal Accounting Officer James Kihara sold 11,421 shares for a transaction value of approximately ~$298,000 on June 26, 2026. The sale represented 46.60% of Kihara's direct holdings and reduced di
RPRX or ACAD: Which Is the Better Value Stock Right Now?
12:40pm, Thursday, 09'th Jul 2026
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Royalty Pharma (RPRX) and Acadia Pharmaceuticals (ACAD). But which of these two companies is the bes
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
09:04am, Monday, 06'th Jul 2026
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Carl Segerstrom as Chief People Officer, effective July 6. Carl will lead the company's global
